Innocan Pharma Announces Second Quarter Fiscal year 2026 Results, With Revenue of US$5.25M (CAD 7.3M)
PR Newswire•31/08/2026•16:01 ET
0
Whiz Insights
Innocan Pharma Announces Second Quarter Fiscal year 2026 Results, With Revenue of US$5.25M (CAD 7.3M) PR Newswire
Second Quarter 2026 Results: Gross Margin of 90.9% and Category Leadership
Get started
Create a free account to read the full story.